tenk.fyi

LENZ Therapeutics, Inc.

LENZNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$19.1M

Net Income

-$82.1M

65.0% YoY

EPS

$-2.85

21.8% YoY

Cash

$25.2M

24.9% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade